Construction and characterization of a recombinant chimeric plasminogen activator consisting of a fibrin peptide and a low molecular mass single-chain urokinase

Biochimie

Volumn 83, Issue 11-12, 2001, Pages 1049-1055

  Jiao, Jianwei ^a   Yu, Meimin ^a   Ru, Binggen ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Chimeric; Fibrin peptide; Thrombolysis; Urokinase

Indexed keywords

AMINO ACID; BENZAMIDINE; CHIMERIC PROTEIN; COMPLEMENTARY DNA; FIBRIN; PLASMIN; PROUROKINASE; RECOMBINANT PLASMINOGEN ACTIVATOR; SEPHAROSE; ZINC;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BETA CHAIN; BINDING AFFINITY; BLOOD CLOTTING TIME; CHEMICAL MODIFICATION; CHROMATOGRAPHY; CONCENTRATION (PARAMETERS); DRUG ACTIVITY; DRUG SYNTHESIS; ESCHERICHIA COLI; FIBRINOLYSIS; GENE EXPRESSION; HUMAN; IN VITRO STUDY; MICHAELIS MENTEN KINETICS; MOLECULAR WEIGHT; NONHUMAN; PLASMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN FOLDING; PROTEIN PURIFICATION; THROMBOCYTE AGGREGATION INHIBITION;

ANIMALIA; ESCHERICHIA COLI;

EID: 0035683995     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(01)01352-9     Document Type: Article

References (25)

1. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke
2. Innovative approach to plasminogen activator therapy
3. Activation of plasminogen by Pro-urokinase
4. Cloning and expression of the gene for pro-urokinase in Escherichia coli
5. Fibrinolytic properties of single chain urokinase-type plasminogen activator (pro-urokinase)
6. Purification and characterization of a novel low molecular weight form of single chain urokinase-type plasminogen activator
7. Biochemical and thrombolytic properties of a low molecular weight form (comprising Leu144 through Leu411) of recombinant single-chain urokinase-type plasminogen activator
8. Thermal stability of low molecular weight urokinase during heat treatment: III. Effect of salts, sugars and tween 80
9. Fibrinogen and fibrin
10. Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization, structural requirement, number of binding sites, and species difference
11. Effect of calcium and synthetic peptides on fibrin polymerization
12. Polymerization site in the β chain of fibrin: Mapping of the Bβ1-55 sequence
13. The polymerization and thrombin-binding properties of Des-(B beta 1-42)-fibrin
14. Fibrin(ogen) peptide B beta 15-42 inhibits platelet aggregation and fibrinogen binding to activated platelets
15. DNA sequencing with chain-terminating inhibitors
16. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
17. The fibrin plate method for estimating the fibrinolytic activity
18. Isolation and characterization of urokinase from human plasma
19. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
20. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
21. Comparative kinetic analysis of the activation of human plasminogen by natural and recombinant single-chain urokinase-type plasminogen activator
22. The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activator
23. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding
24. Function of disintegrin-like/cysteine-rich domain of atrolysin A
25. Function properties of a recombinant chimeric protein with combined thrombin inhibitory and plasminogen-activating potential